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Aquatic environmentAbstract Photocatalysis is one of the most effective advanced oxidation processes to remove resid-
ual pharmaceuticals from the aquatic environment. b-Blockers are the group of pharmaceuticals
commonly found in the environment and are showing potential risk to the aquatic and terrestrial
organisms. This paper provides an overview of different photocatalytic procedures found in the lit-
erature for the abatement of b-blockers.
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Beta (b)-blockers are a class of drugs used to treat a variety of
cardiovascular diseases, such as hypertension, coronary artery
disease and cardiac arrhythmias, by blocking the action of
adrenaline and noradrenaline on the b-adrenergic receptors
in the body, primarily in the heart (Maurer et al., 2007). The
most commonly used b-blockers are atenolol, propranolol
and metoprolol, and the structures of those are shown in
Fig. 1. Propranolol was the ﬁrst clinically successful b-blocker
developed (De la Cruz et al., 2013) and it has the highest acute
and chronic toxicity within the class of b-blockers followed bymetoprolol (Christensen et al., 2009; Fent et al., 2006; Maurer
et al., 2007).
The presence of active pharmaceutical ingredients (APIs) in
the aquatic environments was reported as early in the 1980s
(Richardson and Bowron, 1985). It is an emerging environ-
mental issue and provides a new challenge to drinking water,
wastewater and water reuse treatment systems (Ikehata et al.,
2006). The most important sources of pharmaceutical com-
pounds in the environment are APIs administered to the
patient’s excreted either as metabolites or as the unchanged
parent compounds, hospitals, pharmaceutical industry waste,
and rejected drugs from households, waste water treatment
plants and intensive animal breeding farms (Fatta et al.,
2007). Pharmaceutical residues have been detected in many
environmental matrices worldwide at concentrations ranging
from ng/L to lg/L (Benner et al., 2009; Nicolaou et al.,
2007; Santos et al., 2009; Ternes and Joss, 2006).This is of
great concern in particular because of their potential impact
on terrestrial and aquatic ecosystems and public health
(Bendz et al., 2005; Cleuvers, 2005; Sharma, 2008).10.1016/
Figure 1 Chemical structures of (i) atenolol (ii) metoprolol (iii)
propranolol.
2 V.K. Marothu et al.The occurrence of b-blockers has been repeatedly reported
in recent years in the efﬂuents of many wastewater treatment
plants around the world (Brun et al., 2006; Carlsson et al.,
2009; Conkle et al., 2008; Gabet-Giraud et al., 2010; Huggett
et al., 2003; Joakim Larsson and Fick, 2009; Liu and
Williams, 2007; Nikolai et al., 2006; Sacher et al., 2001;
Ternes, 1998). These compounds are persistent against biolog-
ical degradation and natural attenuation, and therefore, may
remain in the environment for a long time. Conventional
wastewater treatment using activated sludge (Paxeus, 2004) is
not effective in removing these compounds completely. The
promising technology for the treatment of wastewaters con-
taining pharmaceuticals is advanced oxidation processes
(AOPs) (Dantas et al., 2011; Klavarioti et al., 2009). These
techniques are based on the generation of hydroxyl radicals,Figure 2 Principles of pho
Please cite this article in press as: Marothu, V.K. et al., Photocatalysis of b-blockers
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Among AOPs, photocatalysis is an effective, low cost, environ-
mental friendly and sustainable treatment technique. This
process is based on the interaction of light and a semiconduc-
tor (catalyst). The most effective photocatalyst for this purpose
is titanium dioxide (TiO2) (Malato et al., 2002). A photon with
energy higher than TiO2 band gap (3.2 eV for anatase and
3.0 eV for rutile) arrives to the catalyst surface, an electron is
photo excited from the valence to the conduction band;
the wavelength range with energy higher than TiO2 band gap
is k< 390 nm. This mechanism generates electron–hole pairs
on the semiconductor surface which lead to a chain of redox
reactions related to organic contaminants degradation
(Fig. 2) (Chong et al., 2010). The photocatalytic oxidation of
an organic species often proceeds via adsorption of the
contaminant on the surface of the catalyst, followed by direct
subtraction of the contaminant’s electrons by positively
charged holes. Another possible way is oxidation with OH rad-
icals, generated from water of the aqueous environment, which
takes place at the catalyst surface or in its vicinity. Both
reactions may proceed simultaneously and which mechanism
dominates depends on the chemical and adsorption properties
of the contaminant. This review article provides an overview of
different photocatalytic procedures found in the literature for
the abatement of b-blockers in the aquatic environment.
2. Photocatalytic works on b-blockers
Yang et al. (2010) performed photocatalytic degradation kinet-
ics of three b-blockers (atenolol, metoprolol and propranolol)
in aqueous solution using Pyrex reactor. The light source used
was high pressure mercury lamp and the photocatalyst was
Degussa P25 (commercial TiO2 powder). The three drugs were
completely degraded within 40 min irradiation, using a TiO2
concentration of 2.0 g/L. The degradation of the three drugs
followed pseudo-ﬁrst-order kinetics and degradation occurred
mainly on the surface of TiO2 by oxidation reactions withtocatalysis using TiO2.
– An overview. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/
i = the number of aromatic rings, and R = the substituted group on aromatic ring. atenolol: i = 1, 
R = NH2COCH2-,; metoprolol: i = 1, R = CH3OCH2 CH2-,; propranolol: i = 2, R = H. 
Figure 3 General scheme of degradation pathways for b-blockers (Yang et al., 2010).
Photocatalysis of b-blockers 3photohole (h+) or OH radicals. Degradation intermediates
were completely mineralized to CO2 and nitrogen (predomi-
nantly as NH3/NH4
+) within 240 min. The major degradation
pathways for the three b-blockers were cleavage of side chain
(–CH (OH) CH2 NH CH (CH3)2) and addition of –OH group
to the parent compound. General scheme of degradation path-
ways for b-blockers is shown in Fig. 3 (Yang et al., 2010).
Ioannou et al. (2011) investigated decomposition of
b-blockers (atenolol and propranolol) by means of TiO2
photocatalysis using solar simulator in water and wastewater.
Irradiation was provided by a 1 Kw Xe-OP lamp and photo-
catalyst used was Degussa P25. Different commercially
available TiO2 catalysts (Degussa P25, Hombicat UV100,
Aldrich, Tronox AK-1, Tronox TRHP-2, Tronox TR) were
used in the study and found that Degussa P25 is showing
higher photocatalytic activity. This is due to its structure which
is a mixture of anatase and rutile, and slower electron/hole
recombination on the surface of Degussa P25. After 120 min
of irradiation with Degussa P25 80% of the drug was decom-
posed. Degradation was favored in pure water compared with
the wastewater because the latter contains dissolved organic
carbon (DOC) and radical scavengers which show detrimental
effect on conversions.
Toxicity of atenolol and propranolol before and after the
photocatalytic treatment was evaluated by using Daphnia
magna. Toxicity increased during the early stages of photocat-
alytic treatment for either substrate and then gradually
decreased on prolonged treatment due to elimination of the
substrate and its toxic reaction intermediates.
Ji et al. (2013) investigated photocatalytic degradation of
atenolol in pH 6.8 Milli-Q water and river water using TiO2 as
catalyst. Efﬁciency of the four different TiO2 catalysts (Hombi-
catUV100,MillenniumPC500, Aldrich rutile andDegussa P25)
was also investigated. Degussa P25 exhibited the highest photo-
catalytic activity. Complete degradation of atenolol was
obtained after 60 min and 180 min of irradiation in pH 6.8
Milli-Q water and river water, respectively. Atenolol was
degraded to 3-(isopropylamino)propane-1,2-diol, p-hydroxyph-
enylacetamide and 4-[2-hydroxy-3-(isopropylamino)propoxy]Please cite this article in press as: Marothu, V.K. et al., Photocatalysis of b-blockers
j.arabjc.2014.10.044benzaldehyde through ether chain cleavage, hydroxylation
and loss ofCONH2 fromacetamide function group respectively.
Hydroxy radical (HO) was the predominant reactive species
involved in the photocatalytic degradation of atenolol. Possible
photocatalytic degradation pathways of atenolol are shown in
Fig. 4. Intermediates formed during the photocatalysis further
oxidized to ﬁve carboxylic acids namely oxalic, glyoxylic,
malonic, oxamic and formic acid. In the river water atenolol
degradation was slow due to the presence of inorganic ions
and natural radical scavengers (Cl, CO3
2, HCO3
 and dis-
solved organic matter). Inorganic ions compete for the active
sites on the TiO2 surface or they form salt layer on the TiO2
surface and reducing/blocking the accessibility of catalyst and
substrate (atenolol). Natural radical scavengers present in the
river water reduce the HO concentration and thereby decreas-
ing the photocatalytic efﬁciency.
Romero et al. (2011) investigated the degradation of meto-
prolol and propranolol by photocatalysis. Photocatalytic
experiments were carried out with 0.4 g/L of TiO2 as catalyst,
50 mg/L of both drugs and xenon lamp as irradiation source.
Metoprolol and propranolol were completely removed after
300 and 360 min of irradiation, respectively. Biodegradability
and toxicity tests were performed to assess the suitability of
the photocatalytic treatment. Untreated samples were not bio-
degradable and treated samples were biodegradable through
oxidation promoted by hydroxyl radicals. Biodegradability
of the metoprolol was faster compared with the propranolol.
Acute toxicity of both compounds prior and after the treat-
ment was determined by measuring the inhibition of Vibrio
ﬁscheri bioluminescence. Toxicity of the metoprolol was
reduced from the beginning of the treatment but for propran-
olol more toxic intermediates than the primary compound
were formed in the early-stage of reaction, after 30 min of
irradiation, the toxicity was decreased continuously.
De la cruz et al. (2013) assessed the propranolol degrada-
tion by direct photolysis and TiO2 photocatalysis using solar
and artiﬁcial (Xe-lamp) light. In this study photo-reactors
made with quartz and Duran were tested and found that
quartz reactor given signiﬁcant propranolol degradation. In– An overview. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/
Figure 4 Photocatalytic degradation pathways for atenolol in aqueous TiO2 suspensions (Ji et al., 2013).
4 V.K. Marothu et al.the direct photolysis, after 240 min of irradiation 77% and
71% of the drug was degraded by the solar plant and the lab-
oratory device (artiﬁcial light), respectively. Mineralization
observed was 7% in the solar plant and 2% in the laboratory
device.
In the photocatalysis treatment, concentration of TiO2 used
was 0.4 g/L and the degradation observed after 240 min of
irradiation was 81% for the solar plant and 94% for lab
device. Meanwhile mineralization reached was 30% and 41%
in solar plant and laboratory device, respectively.
This study shown that photocatalysis is better than the pho-
tolysis in the propranolol degradation and mineralization.
Mineralization was negligible in the photolysis compared with
the photocatalysis because there are no other photosensitive
compounds in water to generate hydroxyl radicals which are
main reactive species for propranolol removal.
Rivas et al. (2010) investigated the efﬁciency of several
UV-C radiation based methods for the mineralization of meto-
prolol. Mineralization was performed by means of UV-C,
UV-C/H2O2, UV-C/percarbonate, UV-C/monopersulphate,
UV-C/TiO2, UV-C/H2O2/TiO2 and photo-Fenton (Fe
2+ and
H2O2) reagent. Under UV-C radiation mineralization degree
was negligible; addition of free radical promoters/photocata-
lysts signiﬁcantly increases the degradation rate. Among the
tested systems photo-Fenton reagent showed maximum
efﬁciency (70% mineralization) due to three simultaneous
actions in the process, direct photolysis, H2O2 photolysis and
Fenton’s reagent.
Czech and Rubinowska (2013) investigated the photocata-
lytic degradation of metoprolol in the tube reactor using four
different commercially available TiO2 samples (TiO2-Tytanpol
(T1), TiO2-Sigma–Aldrich (T2), Hombikat-Sigma–Aldrich
(T3) and TiO2-S21-Sigma–Aldrich (T4)) differed in speciﬁc
surface area, pore volume and rutile presence. Brunauer–
Emmett–Teller (BET) surface areas (m2/g) of T1, T2, T3 and
T4 were 12.08, 11.50, 61.03 and 55.33, respectively. Metoprolol
was most effectively removed by T3 and least effectively by T2.Please cite this article in press as: Marothu, V.K. et al., Photocatalysis of b-blockers
j.arabjc.2014.10.044This study indicates that photocatalyst with highest BET sur-
face area (T3) revealed the highest activity and lowest BET
surface area (T2) revealed the lowest activity in metoprolol
photocatalytic oxidation.
Ji et al. (2012) investigated the nitrate-induced photolysis
behavior of atenolol and toxicity of its degradation products.
Photolysis experiments were conducted under simulated solar
irradiation using 1000 W Xe arc lamp. Inﬂuence of pH, bicar-
bonate concentration and dissolved organic matter (DOM)
was also studied. Increase in the nitrate concentration
increases the rate of reaction due to generation of hydroxyl
radicals upon irradiation of nitrate solution.
Increase in pH decreases the reaction rate of atenolol by
decreasing the rate of generation of hydroxyl radicals during
irradiation of nitrate. Increase in bicarbonate concentration
decreases the photodegradation rate of atenolol due to increase
in pH and hydroxyl radical scavenging effect.
The presence of DOM decreases the photolysis rate con-
stant; this is due to competition between DOM and nitrate
ions for the photons. Less number of photons is available
for exciting nitrate and thereby decreased the generation of
hydroxyl radicals. During the photocatalysis process atenolol
and its degradation products were monitored by HPLC and
LC–MS. The major pathways of atenolol degradation were
hydroxylation and side chain cleavage .The toxicity of the
phototransformation products was evaluated by using
Daphnia magna and the results revealed that they are less toxic.
This study suggested that photodegradation was an important
pathway for atenolol toxicity reduction in natural water
containing relatively high concentration of nitrate.
Rey et al. (2012) prepared and characterized a TiO2 mag-
netic activated carbon catalyst to mineralize metoprolol tar-
trate. The photocatalytic activity of the TiO2 magnetic
activated carbon catalyst was tested by performing degrada-
tion of metoprolol (Initial Concentration: 10 and 50 mg/L)
under simulated solar photocatalytic ozonation. The results
obtained were compared with those obtained from the– An overview. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/
Figure 5 The proposed pathways for the Fe(III)-citrate-induced
photodegradation of propranolol (Chen et al., 2011).
Photocatalysis of b-blockers 5experiments of single adsorption (i.e., absence of radiation and
ozone), single ozonation (i.e., absence of radiation and cata-
lyst), catalytic ozonation (i.e., absence of radiation), photolytic
ozonation (i.e., absence of catalyst), TiO2 photocatalysis (i.e.,
absence of ozone) and photocatalytic ozonation with Degussa
P25. Among the tested experimental conditions photocatalytic
ozonation with Degussa P25 or TiO2 magnetic activated car-
bon catalyst shown higher metoprolol removal rate and total
organic carbon (TOC) degradation (mineralization) due to
the production of large number of hydroxyl radicals. It was
observed that efﬁciency of TiO2 magnetic activated carbon cat-
alyst was somewhat lower than that of the Degussa P25, even
though, the prepared catalyst is an interesting alternative
material for photocatalysis due to its stability and reusability.
Photolytic ozonation was also equally effective that of photo-
catalytic ozonation when using a metoprolol initial concentra-
tion of 10 mg/L, this result provides a new way, solar
photolytic ozonation for the degradation of emerging contam-
inants from water.
Abramovic et al. (2011) investigated the photocatalytic deg-
radation of metoprolol tartrate in suspensions of two TiO2-
based photocatalysts (Degussa P25 or Wackherr) with differ-
ent surface area. TiO2 Wackherr has 6 times less surface area
than Degussa P25. Faster degradation was observed with
TiO2 Wackherr compared to Degussa P25 due to lesser radia-
tion scattering and slower back reactions, which compensate
the lower surface area of TiO2 Wackherr. In case of Degussa
P25 slower initial degradation rate was observed due to higher
radiation scattering and back reactions. After 240 min of irra-
diation metoprolol was mineralized completely in both the
cases. Degradation intermediates were detected and identiﬁed
by LC–DAD and LC–MS/MS techniques. Major degradation
pathways involved in the photocatalysis of metoprolol are
hydroxylation of the aromatic ring, shortening of the meth-
oxyl-containing lateral chain and cleavage of, or addition of
hydroxyl radical to, the amine-containing chain.
Santiago-Morales et al. (2013) studied visible light photo-
catalytic degradation of propranolol using cerium doped tita-
nium dioxide as catalyst in ultrapure water and biologically
treated wastewater. Cerium doping of TiO2 increases the pho-
tocatalytic efﬁciency of TiO2 by shifting its absorption from
near UV region of the solar spectrum to the visible region.
Photocatalysis of propranolol was carried out in a Duran
tubular photoreactor with the concentration of 25 mg/L and
radiation source is Xe-OP lamp with a photon ﬂux of
(6.19 ± 0.20) · 106 Einstein/s (290–400 nm). Propranolol
was completely disappeared in less than 2 h of irradiation.
Photocatalytic rate was less in biologically treated wastewater
compared with ultrapure water due to the presence of radical
scavengers and competing substances. More than thirty reac-
tion intermediates were formed during the process and those
were detected by liquid chromatography coupled to quadru-
pole-time-of-ﬂight mass spectrometry (LC-ESI-QTOF-MS/
MS). The major degradation pathways of the propranolol
are cleavage of the ether bond and addition of hydroxyl groups
to the aromatic nuclei or to the ring opening attack of hydro-
xyl radicals on the naphthol moiety. The toxicity of the degra-
dation products was determined using the green algae
Pseudokirchneriella subcapitata and the marine bacterium
Vibrio ﬁscheri. Multigenerational toxicity was assessed by
measuring the growth inhibition of P. subcapitata and acute
toxicity was evaluated by measuring the decrease in thePlease cite this article in press as: Marothu, V.K. et al., Photocatalysis of b-blockers
j.arabjc.2014.10.044constitute bioluminescence of V. ﬁscheri. Toxicity study
revealed that, degradation of propranolol in ultrapure water
showed toxicity in the early stage of irradiation treatment
due to accumulation of transformation products but in case
of propranolol spiked wastewater toxicity was not observed
due to lower rate of oxidation.
Chen et al. (2011) investigated the photodegradation of
propranolol by Fe(III)–citrate complexes and effect of metal
ions (Ca2+, Mg2+, Mn2+ and Cu2+) and humic substances
on the photoreactivity of Fe(III)–citrate complexes. Fe(III)–
citrate complexes are excellent photocatalysts by generation
of hydroxyl radicals, which are main reactive oxygen species
responsible for the photodegradation of propranolol. Metal
ions inhibited the photodegradation of propranolol by com-
petitive complexation with Fe(III) for citrate and the inhibition
effect was in the order of Mn2+ > Cu2+ > Ca2+ >Mg2+.
The presence of humic substances also suppressed the photo-
degradation of propranolol by competitive complexation of
humic substances with citrate for Fe(III). The photolysis
experiments were performed in Pyrex vessel under 150-W
Xenon Short Arc Lamp and the degradation products formed
were identiﬁed by GC–MS. 4-hydroxypropranolol, naphtha-
len-1-ol, 1,5-dihydroxy-naphthalene, 1,6-dihydroxy-naphtha-
lene, some benzene series compounds, and low-molecular-
weight carboxylic acids were formed upon photodegradation
of propranolol in Fe(III)–citrate system. The proposed
pathways for the Fe(III)–citrate-induced photodegradation
of propranolol are shown in Fig. 5 (Chen et al., 2011).– An overview. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/
Table 1 Summary of the works published on the photocatalysis of b-blockers.
b-Blocker Matrix Initial
concentration
Catalyst Irradiation source Analytical Methods % removal References
Metoprolol Distilled water 0.05 mM Degussa P25 (1.0 mg/mL),
TiO2 Wackherr
(1.0 mg/mL)
UV HPLC, TOC, HPLC/MS–MS Complete in 30 min for TiO2
Wackherr and 60 min for
Degussa P25
Abramovic et al.
(2011)
Propranolol Deionized water 0.00002 M Fe(III)–citrate complex 150 W xenon short arc lamp HPLC, GC–MS 50 in 37 min Chen et al. (2011)
Metoprolol Water 50 mg/dm3 T1, T2, T3 and T4 UV lamp (254 nm, 0.7 Kw) UV–Vis spectroscopy COD 50 in 120, 145, 210 and
113 min for T1,T2, T3
and T4, respectively
Czech and
Rubinowska (2013)
Propranolol Milli-Q water 50 mg/L Degussa P25 (0.4 g/L) 1 Kw Xe-OP lamp, Sun light HPLC, TOC, BOD5, COD,
Toxicity bioassay by
Chlorella vulgaris
81 for sun light and 94
for Xe-lamp in 240 min
De la cruz et al.
(2013)
Metoprolol Water 0.05 mM Mesoporous TiO2
nanopowder (1 mg/cm3)
UV HPLC Complete in 60 min Golubovic et al.
(2013)
Atenolol
propranolol
Pure water and treated
municipal water
5–30 mg/L Degussa P25
(50–3000 mg/L)
1 Kw Xe-OP lamp Spectrophotometer, TOC,
Toxicity bioassay by D. magna
80 in 120 min Ioannou et al.
(2011)
Atenolol pH 6.8 Milli-Q water
and river water
37.6 lM Degussa P25 (2.0 g/L) High pressure mercury lamp
(Emax = 365 nm)
HPLC, TOC, HPLC/MS–MS Complete in 60 and
180 min in pH 6.8 Milli-Q
water and river
water, respectively
Ji et al. (2013)
Atenolol Milli-Q water 40 lM Sodium nitrate (5 mM) 1000 W Xe arc lamp HPLC, TOC, HPLC/MS–MS,
Toxicity
bioassay by D. magna
72 in 240 min Ji et al. (2012)
Metoprolol Aqueous solution 50 mg/L Titania – coated magnetic
activated carbon
1500 W xenon arc lamp
(k> 300 nm, 550 W/m2)
HPLC, TOC Complete in 3 h Rey et al. (2012)
Metoprolol Aqueous solution 0.0001 M Degussa P25 Low pressure mercury lamp
(Emax = 254 nm)
HPLC, TOC 30 for UV-C/1 g/L TiO2
system and 45 for UV-C/
0.001 M H2O2/ TiO2
(0.25–2.0 g/L) system
in 180 min
Rivas et al. (2010)
Metoprolol
propranolol
Milli-Q water 50 mg/L Degussa P25 (0.4 g/L) 1 Kw Xe-OP lamp HPLC, TOC, BOD5, COD,
Toxicity bioassay by Vibrio ﬁscheri
Complete in 300 min
for metoprolol and
360 min for propranolol
Romero et al.
(2011)
Propranolol Ultrapure water,
biologically treated
wastewater
25 mg/L Ce-doped TiO2 (cerium
loading of 0.5 wt.%
and bulk catalyst
concentration
of 0.14 g/L)
1 Kw Xe-OP lamp HPLC, TOC, COD, Toxicity
bioassay by P. subcapitata
and Vibrio ﬁscheri
Complete in 90 min in
pure water and 360 min
in wastewater
Santiago-Morales
et al. (2013)
Atenolol
Metoprolol
Propranolol
Milli-Q water 100 lM Degussa P25 (2.0 g/L) High pressure mercury lamp
(Emax = 365 nm)
HPLC, TOC, HPLC/MS–MS Complete in 40 min Yang et al. (2010)
Abbreviations:
HPLC-MS/MS: High performance liquid chromatography-tandem mass spectrometry.
TOC: Total organic carbon.
BOD5: Biochemical oxygen demand.
COD: Chemical oxygen demand.
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Photocatalysis of b-blockers 7Golubovic´ et al. (2013) investigated the efﬁciency of sol–gel
synthesized mesoporous TiO2 nanopowders for photocatalytic
degradation of metoprolol. Mesoporous TiO2 nanopowders
have been synthesized by using titanium tetrachloride (TiCl4)
as the precursor. The photocatalytic efﬁciency of the mesopor-
ous TiO2 was compared with Degussa P25 and effect of calci-
nation time (1–7 h) on photocatalytic activity of mesoporous
TiO2 was investigated. The mesoporous TiO2 samples calcined
for 4 h have displayed higher photocatalytic performance com-
pared with other calcination time samples due to greater mean
pore diameter and the pore structure complexity. Samples
calcined for 4 and 5 h have displayed higher photocatalytic
performance compared with Degussa P25, whereas the sample
calcined for 3 h has shown similar activity. This study
indicated that, photocatalytic degradation of metoprolol was
strongly effected by pore size and morphology of TiO2
nanopowders.
An overview of the works published on the photocatalysis
of b-blockers is presented in Table 1.3. Summary
In recent years, the presence of b-blockers in environmental
matrices has received a special attention by the scientiﬁc com-
munity due to increasing use and limited human metabolism
(Alder et al., 2010; Huggett et al., 2003; Rivas et al., 2010).
After being used, they are released into sewage waste water
treatment system and surface waters as metabolites as well as
unchanged parent molecules. These compounds are persistent
and resistant to biodegradation, accumulating in the environ-
ment. They are producing harmful effects (changes in cardiac
rhythm, generation of abnormalities, inhibition of the growth
of human embryonic cells or reduce mobility of spermatozoids
of ﬁsh) to aquatic and terrestrial ecosystems (Cleuvers, 2005;
Pomati et al., 2006).
Conventional waste water treatments such as activated
sludge, granular activated carbon ﬁltration and ozonation
were not effective in the removal of these compounds
(Maurer et al., 2007; Paxeus, 2004; Vieno et al., 2007) requiring
the development of new efﬁcient methodologies. Several stud-
ies have reported that AOPs appear as good alternative for the
degradation of b-blockers (Andreozzi et al., 2004; Medana
et al., 2008; Song et al., 2008; Ternes et al., 2002).
Photocatalysis is an example of AOPs capable of achieving
complete oxidation of organic and inorganic species (Calza
et al., 2006; Doll and Frimmel, 2005). The catalyst employed
for almost all the photocatalytic treatment studies of b-blockers
is Degussa P25. It contains 80:20 anatase:rutile shows excep-
tional activity. Photocatalytic performance of mesoporous
TiO2 nanopowders was high due to greater surface area and
optimal exposure of organic molecules to light via facilitation
of diffusion of organic molecules to the active sites (Tan et al.,
2011; Yu et al., 2007). Doping of TiO2 with cerium increases
the photocatalytic efﬁciency due to shifting of its absorption
from near UV region to the visible region and facile formation
of labile oxygen vacancies. Stability of the TiO2 was increased
by preparing TiO2 magnetic activated carbon catalyst, which is
reusable. TiO2 photocatalysis with ozonation is a promising
technology for degradation of drugs in the aquatic environ-
ment. In this combined process larger number of hydroxyl
radicals was produced compared with single ozonation orPlease cite this article in press as: Marothu, V.K. et al., Photocatalysis of b-blockers
j.arabjc.2014.10.044TiO2 photocatalysis. Finally photocatalysis is an efﬁcient and
inexpensive treatment technique for the removal of b-blockers
from the aquatic environment.
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